Unsuccessful rechallenge with nivolumab in a patient with advanced non‐small cell lung cancer who had a 6‐year complete response and treatment‐free period: Case report

Documenti analoghi

• Can FDG‐PET after neoadjuvant chemotherapy plus nivolumab predict residual disease in non‐small cell lung cancer?
  di: Hideto Iguchi, et al.
  Pubblicazione: (2024)
• Neoadjuvant nivolumab plus chemotherapy followed by resection for superior sulcus tumour with high PD‐L1 expression: A case report
  di: Takahito Nakaya, et al.
  Pubblicazione: (2024)
• Effective management of lung spindle cell carcinoma with ipilimumab, nivolumab, carboplatin, and paclitaxel, demonstrating efficacy in brain metastases treatment
  di: Susumu Noguchi, et al.
  Pubblicazione: (2024)
• Achieving complete metabolic response in stage IV lung adenocarcinoma with chemotherapy, nivolumab, ipilimumab, and salvage SBRT: A case report
  di: Salvador Gamez Casado, et al.
  Pubblicazione: (2024)
• Drug‐induced lung injury in a patient treated with prior atezolizumab and subsequent sotorasib: A case report
  di: Yuta Takahashi, et al.
  Pubblicazione: (2024)